BlackRock Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $68.5M | Sell |
1,888,452
-4,652,768
| -71% | -$169M | 0.07% | 256 |
|
|
2016
Q3 | $301M | Sell |
6,541,220
-1,380,961
| -17% | -$63.5M | 0.31% | 77 |
|
|
2016
Q2 | $398M | Buy |
7,922,181
+1,084,314
| +16% | +$54.5M | 0.4% | 53 |
|
|
2016
Q1 | $366M | Sell |
6,837,867
-1,213,841
| -15% | -$65M | 0.38% | 59 |
|
|
2015
Q4 | $529M | Buy |
8,051,708
+302,238
| +4% | +$19.8M | 0.56% | 35 |
|
|
2015
Q3 | $438M | Sell |
7,749,470
-2,691,241
| -26% | -$152M | 0.47% | 42 |
|
|
2015
Q2 | $617M | Buy |
10,440,711
+605,277
| +6% | +$35.8M | 0.64% | 29 |
|
|
2015
Q1 | $613M | Buy |
9,835,434
+1,090,929
| +12% | +$68M | 0.63% | 29 |
|
|
2014
Q4 | $503M | Buy |
8,744,505
+2,649,866
| +43% | +$152M | 0.51% | 44 |
|
|
2014
Q3 | $328M | Buy |
6,094,639
+2,705,336
| +80% | +$145M | 0.33% | 71 |
|
|
2014
Q2 | $178M | Buy |
3,389,303
+1,447,801
| +75% | +$75.9M | 0.17% | 140 |
|
|
2014
Q1 | $103M | Buy |
1,941,502
+699,602
| +56% | +$37M | 0.1% | 221 |
|
|
2013
Q4 | $49.8M | Sell |
1,241,900
-136,676
| -10% | -$5.48M | 0.05% | 336 |
|
|
2013
Q3 | $52.1M | Buy |
1,378,576
+466,913
| +51% | +$17.6M | 0.05% | 315 |
|
|
2013
Q2 | $35.7M | Buy |
+911,663
| New | +$35.7M | 0.04% | 379 |
|